Quick Order Cart

Cat. No. ARG34663

KIF3A Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

The KIF3A Knockout HAP1 Polyclonal Cells offer a CRISPR/Cas9-edited polyclonal knockout population in the near-haploid HAP1 cell line, disrupting the KIF3A motor subunit of kinesin-2. KIF3A drives anterograde intraflagellar transport (IFT) and is essential for ciliogenesis and Hedgehog signaling, interacting with partners such as KIF3B and KAP3 to transport ciliary cargo. This model enables investigation of ciliary biology, ciliopathies, and ciliary-dependent signaling through immunofluorescence for ciliary markers, Gli-luciferase reporter assays, and RT-qPCR. It is ideal for drug screening and functional analysis of IFT-related diseases.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    KIF3A

    Gene Identifier

    NCBI Gene ID 11127

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The KIF3A Knockout HAP1 Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout cell population targeting the KIF3A gene in the HAP1 near-haploid human cell line. This polyclonal pool contains diverse KIF3A-disrupted alleles generated by CRISPR/Cas9-mediated gene disruption, offering a mixed genotype for loss-of-function studies without single-cell cloning artefacts. The population format is well-suited for pooled screens, bulk biochemical analyses, and initial functional characterization of KIF3A-dependent processes.

HAP1 cells are derived from a male chronic myeloid leukemia patient and carry the BCR-ABL1 fusion oncogene while maintaining a stable near-haploid karyotype. This haploid genome simplifies genetic analysis by permitting unambiguous gene disruption, as a single targeting event eliminates gene function. The cell line is compatible with standard culture conditions, high-throughput imaging, and a broad range of biochemical and genetic assays, making it a versatile host for studying ciliary biology and signaling pathways.

KIF3A encodes the catalytic motor subunit of the heterotrimeric kinesin-2 complex, which also includes the KIF3B motor subunit and the adaptor protein KAP3 (KIFAP3). This motor complex drives anterograde intraflagellar transport (IFT) along ciliary axonemes, delivering cargo essential for ciliogenesis and ciliary signaling. KIF3A interacts directly with multiple IFT-B complex components, such as IFT20 and IFT88, and its function is critical for Hedgehog pathway activation by facilitating the proper localization and processing of Smoothened and Gli transcription factors. Upstream regulators including RFX transcription factors and FoxJ1 control KIF3A expression during ciliogenesis, while downstream targets encompass tubulin, ciliary membrane proteins, and the polycystin complex. Disruption of KIF3A therefore impairs IFT, leading to defective cilia assembly and attenuated Hedgehog and Wnt/??-catenin signaling.

In the HAP1 near-haploid background, KIF3A knockout provides a clean genetic model to dissect ciliary biology and ciliopathy mechanisms without diploidy complications. The loss-of-function phenotype allows direct assessment of defective ciliogenesis, aberrant Hedgehog transduction, and potential effects on planar cell polarity and cell cycle regulation. This system is particularly valuable for modeling ciliopathies such as polycystic kidney disease, retinitis pigmentosa, and Joubert syndrome, as well as cancers where ciliary signaling is deregulated, including medulloblastoma and breast cancer.

Researchers can employ immunofluorescence staining for ciliary markers such as Arl13b and acetylated ??-tubulin to quantify cilia length and frequency, western blotting for KIF3A and downstream effectors, and Gli-luciferase reporter assays to measure Hedgehog pathway activity. RT-qPCR analysis of Hedgehog target genes and flow cytometry-based detection of ciliation status enable detailed molecular phenotyping. The KIF3A Knockout HAP1 Polyclonal Cells are also suitable for high-content screening of cilia-modulating compounds and mechanistic studies of intraflagellar transport. For additional technical information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)